Get the Stockscreener App
0.6169
1.91%
-0.012
After Hours:
.64
0.0231
+3.74%
Dariohealth Corp stock is traded at $0.6169, with a volume of 161.70K.
It is down -1.91% in the last 24 hours and down -27.59% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$0.6289
Open:
$0.66
24h Volume:
161.70K
Relative Volume:
0.31
Market Cap:
$23.68M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-0.5989
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
-3.62%
1M Performance:
-27.59%
6M Performance:
-38.27%
1Y Performance:
-66.83%
1-Day Range:
$0.6089
$0.66
1-Week Range:
$0.57
$0.66
52-Week Range:
$0.56
$2.60
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.6169 | 23.68M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
DarioHealth inks deal with Blue Cross Blue Shield - Investing.com
DarioHealth Expands Digital Health Empire with Landmark BCBS DealAI Platform Set to Transform $1.2T Market - StockTitan
Comparing DarioHealth (NASDAQ:DRIO) and PROCEPT BioRobotics (NASDAQ:PRCT) - Defense World
DarioHealth (NASDAQ:DRIO) Stock Rating Lowered by TD Cowen - Defense World
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Business Wire
DarioHealth stock hits 52-week low at $0.63 amid market challenges - MSN
TD Cowen cuts DarioHealth stock rating amid growth concerns - MSN
TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2 - Marketscreener.com
DarioHealth Corp. Secures $25.6 Million Private Placement to Support Strategic Operational Objectives - Defense World
All You Need to Know About DarioHealth (DRIO) Rating Upgrade to Strong Buy - MSN
DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PR Newswire
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
DarioHealth Corp (DRIO): AI Solutions for Health and Wellness - Insider Monkey
DRIODarioHealth Corp. Latest Stock News & Market Updates - StockTitan
DarioHealth Expands Weight Loss Platform With GLP-1 Prescriptions as Stock Surges 14% - StockTitan
DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets - WV News
DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market - Marketscreener.com
DarioHealth Corp. announced that it expects to receive $6.824 million in funding -January 06, 2025 - Marketscreener.com
DarioHealth Corp. (NASDAQ:DRIO) Short Interest Update - Defense World
DarioHealth stock hits 52-week low at $0.64 amid market challenges - Investing.com
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges By Investing.com - Investing.com South Africa
DarioHealth Stock Hits 52-Week Low at $0.66 Amid Market Challenges - Investing.com Canada
DarioHealth Corp confirms new board, ratifies auditors - Investing.com India
DarioHealth Corp confirms new board, ratifies auditors By Investing.com - Investing.com UK
Dario Signs Four New Employer Contracts Across Full Product Suite - The Eastern Progress Online
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges - Investing.com Canada
DarioHealth Stock Hits 52-Week Low at $0.67 Amid Market Challenges By Investing.com - Investing.com South Africa
Dario Announces Complete Integration of Twill Capabilities Across Full Multi-Condition Platform - The Eastern Progress Online
DarioHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
DarioHealth stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada
/C O R R E C T I O N -- DarioHealth Corp./ - GuruFocus.com
DarioHealth to Report Third Quarter 2024 Results on Thursday, No - GuruFocus.com
Twill by Dario to Offer a Benefit for AARP Members - GuruFocus.com
National Medicare Health Plan Partners with Twill by Dario to Pr - GuruFocus.com
DarioHealth secures four new employer contracts for 2025 By Investing.com - Investing.com Canada
DarioHealth secures four new employer contracts for 2025 - Investing.com India
DarioHealth Corp. Signs Four New Employer Contracts Across Full Product Suite - Marketscreener.com
Slammed 25% DarioHealth Corp. (NASDAQ:DRIO) Screens Well Here But There Might Be A Catch - Simply Wall St
DarioHealth Corp. (NASDAQ:DRIO) Q3 2024 Earnings Call Transcript - Insider Monkey
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.82%
3.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):